Cite
HARVARD Citation
Ascierto, P. et al. (2021). Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East. International journal of cancer. 149 (11), pp. 1926-1934. [Online].